Carrier-independent entry of 1-methyl-4-phenylpyridinium (MPP+) into adrenal chromaffin cells as a consequence of charge delocalization
Authors:
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 168 (3) , 1143-1148
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Characterization of Cellular Transport, Subcellular Distribution, and Secretion of the Neurotoxicant 1‐Methyl‐4‐Phenylpyridinium in Bovine Adrenomedullary Cell CulturesJournal of Neurochemistry, 1989
- MPTP Toxicity: Implications for Research in Parkinson's DiseaseAnnual Review of Neuroscience, 1988
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytesBiochemical and Biophysical Research Communications, 1986
- Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomesBiochemical and Biophysical Research Communications, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984
- An approach to computing electrostatic charges for moleculesJournal of Computational Chemistry, 1984
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidaseBiochemical and Biophysical Research Communications, 1984
- Primary culture of adrenal medullary chromaffin cells in a chemically defined mediumExperimental Cell Research, 1981